ALGN
Price
$142.25
Change
-$1.29 (-0.90%)
Updated
Oct 14, 11:01 AM (EDT)
Capitalization
10.3B
14 days until earnings call
Intraday BUY SELL Signals
ICUI
Price
$163.47
Change
+$0.24 (+0.15%)
Updated
Oct 14, 12:01 PM (EDT)
Capitalization
4.1B
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGN vs ICUI

ALGN vs ICUI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALGN vs. ICUI commentary
Oct 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and ICUI is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ALGN with price predictions
Oct 13, 2026

ALGN's RSI Indicator ascending out of oversold territory

The RSI Indicator for ALGN moved out of oversold territory on September 16, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 38 similar instances when the indicator left oversold territory. In 28 of the 38 cases the stock moved higher. This puts the odds of a move higher at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 57 cases where ALGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.

The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on October 08, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 30 of 42 cases over the following month. The odds of a continued upward trend are 71%.

Following a +2.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 192 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

ALGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 50-day moving average for ALGN moved below the 200-day moving average on September 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for ALGN entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. ALGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.434) is normal, around the industry mean (5.011). P/E Ratio (25.174) is within average values for comparable stocks, (163.451). Projected Growth (PEG Ratio) (0.611) is also within normal values, averaging (4.456). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.074).

The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
a Summary for ICUI with price predictions
Oct 13, 2026

ICUI's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ICUI turned positive on September 24, 2026. Looking at past instances where ICUI's MACD turned positive, the stock continued to rise in 39 of 51 cases over the following month. The odds of a continued upward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ICUI's RSI Oscillator exited the oversold zone, 21 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.

Following a +4.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in 193 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICUI as a result. In 63 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.

ICUI moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ICUI crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

The Aroon Indicator for ICUI entered a downward trend on September 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.906) is normal, around the industry mean (5.011). P/E Ratio (137.840) is within average values for comparable stocks, (163.451). Projected Growth (PEG Ratio) (0.081) is also within normal values, averaging (4.456). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.808) is also within normal values, averaging (56.074).

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

FUNDAMENTALS RATINGS
ALGN vs ICUI: Fundamental Ratings
ALGN
ICUI
OUTLOOK RATING
1..100
6611
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6989
PRICE GROWTH RATING
1..100
6240
P/E GROWTH RATING
1..100
25100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (63) in the Medical Specialties industry is in the same range as ICUI (73). This means that ALGN’s stock grew similarly to ICUI’s over the last 12 months.

ALGN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ICUI (100). This means that ALGN’s stock grew similarly to ICUI’s over the last 12 months.

ALGN's SMR Rating (69) in the Medical Specialties industry is in the same range as ICUI (89). This means that ALGN’s stock grew similarly to ICUI’s over the last 12 months.

ICUI's Price Growth Rating (40) in the Medical Specialties industry is in the same range as ALGN (62). This means that ICUI’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's P/E Growth Rating (25) in the Medical Specialties industry is significantly better than the same rating for ICUI (100). This means that ALGN’s stock grew significantly faster than ICUI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNICUI
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
66%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
68%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 6 days ago
70%
Bullish Trend 3 days ago
68%
Declines
ODDS (%)
Bearish Trend 10 days ago
75%
Bearish Trend 8 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
72%
COMPARISON
Comparison
Oct 14, 2026
Stock price -- (ALGN: $143.54 vs. ICUI: $163.23)
Brand notoriety: ALGN: Notable vs. ICUI: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 116% vs. ICUI: 97%
Market capitalization -- ALGN: $10.3B vs. ICUI: $4.1B
ALGN [@Pharmaceuticals: Other] is valued at $10.3B. ICUI’s [@Pharmaceuticals: Other] market capitalization is $4.1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $146.54B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 1 FA rating(s) are green while ICUI’s FA Score has 0 green FA rating(s).

  • ALGN’s FA Score: 1 green, 4 red.
  • ICUI’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGN is a better buy in the long-term than ICUI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 5 TA indicator(s) are bullish while ICUI’s TA Score has 3 bullish TA indicator(s).

  • ALGN’s TA Score: 5 bullish, 3 bearish.
  • ICUI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALGN is a better buy in the short-term than ICUI.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а +1.48% price change this week, while ICUI (@Pharmaceuticals: Other) price change was +2.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.23%. For the same industry, the average monthly price growth was -3.14%, and the average quarterly price growth was +7.32%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 28, 2026.

ICUI is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-1.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
ALGN
Daily Signal:
Gain/Loss:
ICUI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UCO60.551.44
+2.44%
ProShares Ultra Bloomberg Crude Oil (UCO)
IBDW20.08-0.02
-0.10%
iShares iBonds Dec 2031 Term Corporate ETF (IBDW)
FCBD24.61-0.03
-0.12%
Frontier Asset Core Bond ETF
BAMG45.65-0.07
-0.15%
Brookstone Growth Stock ETF (BAMG)
AIUP30.89-0.25
-0.81%
Finq First U.S. Large Cap AI Managed Equity ETF

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been closely correlated with NVST. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALGN jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
+2.22%
NVST - ALGN
71%
Closely correlated
-0.31%
XRAY - ALGN
58%
Loosely correlated
-0.29%
LUNG - ALGN
52%
Loosely correlated
-2.22%
ICUI - ALGN
50%
Loosely correlated
-0.41%
ILMN - ALGN
48%
Loosely correlated
-1.99%
More